Valuation: Attana AB

Market Cap 7.74M 803K 702K 648K 598K 1.14M 76.6M 1.15M 3.04M 37.73M 3.02M 2.95M 130M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 788K 689K 636K 587K 1.11M 75.16M 1.13M 2.98M 37.02M 2.96M 2.89M 127M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
1 week-25.00%
1 month-25.00%
3 months-57.14%
6 months-62.50%
Current year-66.67%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.003
0
Current year 0
Extreme 0.003
0.01
1 year 0
Extreme 0.003
0.03
3 years 0
Extreme 0.003
0.32
5 years 0
Extreme 0.003
1.57
10 years 0
Extreme 0.003
2.4
Manager TitleAgeSince
Chief Executive Officer - 01/04/2025
Chief Executive Officer 56 01/09/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 06/08/2012
Chairman 63 01/10/2015
Director/Board Member 62 01/01/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-25.00%-85.00%-98.16% 803K
-0.72%+4.05%-38.29%-38.20% 612M
+3.09%-8.49%+110.15% - 386M
+3.73%-5.12%-34.47%+34.33% 122M
-2.32%-14.99%+20.41%+84.38% 115M
Average +0.76%-8.83%-5.44%-4.41% 247.19M
Weighted average by Cap. +0.76%-1.24%+13.90%-11.30%

Financials

2024 2025
Net sales 6.61M 686K 600K 554K 511K 970K 65.43M 986K 2.6M 32.23M 2.58M 2.52M 111M 4.01M 416K 364K 335K 310K 588K 39.65M 598K 1.57M 19.53M 1.56M 1.53M 67.15M
Net income -12.78M -1.33M -1.16M -1.07M -988K -1.87M -126M -1.91M -5.02M -62.27M -4.98M -4.87M -214M -10.5M -1.09M -953K -879K -812K -1.54M -104M -1.57M -4.12M -51.19M -4.09M -4M -176M
Net Debt 1.17M 121K 106K 98K 90.52K 172K 11.59M 175K 460K 5.71M 456K 446K 19.62M -145K -15.09K -13.2K -12.17K -11.24K -21.33K -1.44M -21.69K -57.11K -709K -56.65K -55.41K -2.44M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
10/07/26 SEK 0.003000 0.00% 4,846,726
09/07/26 SEK 0.003000 0.00% 20,376,327
08/07/26 SEK 0.003000 -25.00% 33,316,452
07/07/26 SEK 0.004000 0.00% 10,180,288
06/07/26 SEK 0.004000 0.00% 11,549,924
  1. Stock Market
  2. Stocks
  3. ATANA Stock